by Targeted drug delivery refers to formulations that help drugs or therapeutics directly act on diseased organs or tissues, thereby reducing side effects and improving therapeutic benefits. It involves selectively transporting therapeutic substances to targeted sites in the body and releasing them in a controlled manner. Targeted drug delivery systems aim to enhance the therapeutic index of drugs by increasing drug concentration at disease sites and reducing the relative concentration of drugs in normal tissues. Common targeted drug delivery approaches include liposomes, micelles, nanoparticles, antibody drug conjugates, implants, etc. Liposomes are spherical vesicles made of lipid bilayers that can encapsulate hydrophilic as well as hydrophobic drugs. They possess tunable properties like size, permeability and surface properties that allows targeted delivery of encapsulated drugs. Nanoparticles are colloidal solid particles ranging from 1 to 1000 nm that can be engineered for active or passive targeted delivery based on size.
The global Targeted Drug Delivery Market is estimated to be valued at Us$ 151.6 Billion in 2023 and is expected to exhibit a Cagr Of 2.1% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The Targeted Drug Delivery market is expected to flourish due to its ability to reduce side effects. Targeted delivery ensures drugs or therapeutics are delivered directly to desired organs or tissues, thereby reducing systemic exposure and unwanted effects on healthy tissues. Additionally, enhanced permeability and retention effect also makes favorable environment for accumulation of nanoparticles at tumor sites, facilitating targeted delivery of anti-cancer drugs. Reduced side effects along with improved efficacy and adherence to treatment regimens leads to better health outcomes for patients. Further, increasing prevalence of chronic diseases like cancer is another key driver favoring growth of targeted drug delivery systems to manage such conditions effectively.
Segment Analysis
The targeted drug delivery market is dominating by polymer micelles sub segment. Polymer micelles have emerged as promising targeted drug delivery vehicles, as they have the ability to solubilize both hydrophilic and hydrophobic drugs. Polymer micelles can retain the drug at the site of action for extended periods through passive targeting. This property helps in reducing systemic side effects and enhances bioavailability of the encapsulated drug.
PEST Analysis
Political: The governments across the globe are supporting the drug delivery research through funding. For instance, National Institute of Health in the US funds a large number of targeted drug delivery projects annually.
Economic: The high treatment cost of cancer and other chronic diseases drives growth of targeted drug delivery market. Development of advanced targeted therapies help in reducing healthcare costs associated with systemic side effects.
Social: Increasing incidence of chronic diseases and growing patient awareness about advanced treatment options boost demand for targeted therapies. Longer lifespan and desire to lead active life propel research in targeted drug delivery.
Technological: 3D printing, nanotechnology and advance material sciences enabled development of novel targeted drug carriers like nanocarriers, nanoparticles, micelles etc. Continuous innovations help overcome challenges in achieving active targeting.
Key Takeaways
The Global Targeted Drug Delivery Market Demand is expected to witness high growth during the forecast period of 2023 to 2030. The global Targeted Drug Delivery Market is estimated to be valued at US$ 151.6 billion in 2023 and is expected to exhibit a CAGR of 2.1% over the forecast period 2023 to 2030.
Regional analysis :
North America region currently dominates the targeted drug delivery market primarily due to presence of major players and advanced research ecosystem in the region. US and Canada witnessed highest R&D investments in targeted drug delivery technologies.
Key players :
Key players operating in the targeted drug delivery market are Johnson & Johnson, Gilead Sciences, Pfizer, Amgen, Roche, Sanofi, Bayer AG, Novartis, Merck & Co., and AstraZeneca.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
